Advances in epigenetics of nonalcoholic fatty liver desease / 复旦学报(医学版)
Fudan University Journal of Medical Sciences
; (6): 262-267, 2024.
Article
en Zh
| WPRIM
| ID: wpr-1019611
Biblioteca responsable:
WPRO
ABSTRACT
Nonalcoholic fatty liver disease(NAFLD)is a metabolic liver disease that ranges from relatively benign hepatic steatosis to nonalcoholic steatohepatitis(NASH).NASH is characterized by persistent liver damage,inflammation,and fibrosis which significantly increases the risk of end-stage liver diseases,such as liver cirrhosis and hepatocellular carcinoma.The pathogenesis of NAFLD/NASH is not yet fully understood,but its recent epigenetic advances have provided new insights into the mechanisms of this disease.This review summarized recent progress in this area which has laid a solid foundation for elucidating the pathogenesis of NAFLD and provides potential targets for early detection,diagnosis,and treatment of this disease.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
Fudan University Journal of Medical Sciences
Año:
2024
Tipo del documento:
Article